The authors targeted 43 genes involved in N-glycosylation and mannose 6-phosphate processing, individually or in combinations, and showed an improved circulation time and delivery to the heart of glycoengineered alpha-galactosidase capped with α-2,3-linked sialic acid in a Fabry disease mouse model. The gene discussed is GLA; the disease is Fabry disease.